&Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17M | Buy |
703,411
+50,778
| +8% | +$1.23M | 0.13% | 158 |
|
|
2025
Q1 | $16.5M | Buy |
652,633
+89,713
| +16% | +$2.26M | 0.18% | 123 |
|
|
2024
Q4 | $15M | Buy |
562,920
+200,767
| +55% | +$5.34M | 0.18% | 118 |
|
|
2024
Q3 | $10.5M | Buy |
362,153
+186,758
| +106% | +$5.41M | 0.2% | 115 |
|
|
2024
Q2 | $4.91M | Buy |
175,395
+98,606
| +128% | +$2.76M | 0.21% | 106 |
|
|
2024
Q1 | $2.13M | Buy |
76,789
+22,443
| +41% | +$623K | 0.29% | 68 |
|
|
2023
Q4 | $1.59M | Buy |
54,346
+28,846
| +113% | +$842K | 0.39% | 60 |
|
|
2023
Q3 | $846K | Buy |
25,500
+970
| +4% | +$32.2K | 0.39% | 49 |
|
|
2023
Q2 | $900K | Buy |
24,530
+507
| +2% | +$18.6K | 0.4% | 48 |
|
|
2023
Q1 | $980K | Sell |
24,023
-12
| -0% | -$490 | 0.47% | 42 |
|
|
2022
Q4 | $1.23M | Sell |
24,035
-250
| -1% | -$12.8K | 0.61% | 35 |
|
|
2022
Q3 | $1.06M | Buy |
24,285
+1,755
| +8% | +$76.8K | 0.61% | 34 |
|
|
2022
Q2 | $1.18M | Buy |
22,530
+908
| +4% | +$47.6K | 0.68% | 32 |
|
|
2022
Q1 | $1.12M | Buy |
21,622
+15,270
| +240% | +$790K | 0.63% | 29 |
|
|
2021
Q4 | $375K | Buy |
6,352
+8
| +0.1% | +$472 | 0.23% | 101 |
|
|
2021
Q3 | $273K | Buy |
6,344
+10
| +0.2% | +$430 | 0.17% | 134 |
|
|
2021
Q2 | $248K | Buy |
+6,334
| New | +$248K | 0.16% | 141 |
|